| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 12/02/2004 | US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 12/01/2004 | EP1481966A1 Novel arylamidine derivative or salt thereof |
| 12/01/2004 | EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 12/01/2004 | CN1177821C Matrix metalloprotease inhibitors |
| 12/01/2004 | CN1177815C Process for synthesizing dihydroxytin monouclear p-amino-or p-nitro benzoyl hydroxamate match |
| 11/25/2004 | US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 11/25/2004 | US20040235911 hydroxyamidines; antibiotic resistance |
| 11/25/2004 | DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin |
| 11/24/2004 | EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs |
| 11/23/2004 | US6821963 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
| 11/18/2004 | WO2004099124A2 Novel bioisosteres of actinonin |
| 11/18/2004 | WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 11/18/2004 | US20040229955 Antibacterial agents |
| 11/17/2004 | EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 11/11/2004 | WO2004052919A3 Peptide deformylase inhibitors |
| 11/10/2004 | EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 11/03/2004 | EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 10/28/2004 | WO2004092115A2 Hydroxamates as therapeutic agents |
| 10/28/2004 | US20040214956 Synthesis with amidines and curing promoters with high molecular weight |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/21/2004 | US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease |
| 10/21/2004 | US20040209949 Resorcinol derivatives |
| 10/21/2004 | US20040209822 Novel compounds |
| 10/20/2004 | EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467695A2 Hiv integrase inhibitors |
| 10/20/2004 | CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 10/19/2004 | US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds |
| 10/14/2004 | WO2004087133A1 Crystalline n-formyl hydroxylamine compounds |
| 10/14/2004 | WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 10/14/2004 | CA2520682A1 Crystalline n-formyl hydroxylamine compounds |
| 10/13/2004 | CN1170595C Use of hydroxylated carboxylate or amide used as solubilizing agent |
| 10/07/2004 | US20040198830 Carbamic acid compounds comprising an ether linkage as hdac inhibitors |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 09/30/2004 | US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461308A2 Bacterial enzyme inhibitors |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | US20040186301 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP0805148B1 Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide |
| 09/22/2004 | CN1167676C Synthesis of dihydroxytin mononuclear p-chloro, p-fluoro or p-methoxyl-benzoyl hydroxamate complex |
| 09/21/2004 | US6794534 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/14/2004 | US6790834 Cytostatic agents |
| 09/10/2004 | WO2004076432A1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
| 09/10/2004 | WO2004000215A3 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 09/09/2004 | US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/07/2004 | US6787612 Producing such as hydrazyl-carbonyl-amino methylated polystyrene; minimizes solution-phase synthetic steps in solid-phase peptide or peptide analog synthesis |
| 09/07/2004 | US6787522 Antibacterial agents |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/26/2004 | WO2004071401A2 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 08/26/2004 | US20040167184 Treatment of lung cells with histone deacetylase inhibitors |
| 08/26/2004 | US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/24/2004 | US6780863 Treat inflammatory and/or allergic conditions |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/19/2004 | WO2004069900A2 Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions |
| 08/19/2004 | WO2004050620A3 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 08/19/2004 | WO2004048335A3 Mandelic acid derivatives |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/12/2004 | WO2002076395A3 Agents and methods for treatment of cancer |
| 08/12/2004 | US20040157916 Peptide deformylase inhibitors |
| 08/11/2004 | EP1445249A1 Novel bensophenone derivatives or salts thereof |
| 08/11/2004 | EP0760657B9 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/10/2004 | US6774086 Herbicides |
| 08/05/2004 | WO2004065354A1 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 08/05/2004 | WO2004064727A2 Method of cancer treatment using hdac inhibitors |
| 08/05/2004 | WO2004046104A3 Treatment of lung cells with histone deacetylase inhibitors |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | CA2513246A1 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/22/2004 | US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/13/2004 | US6762320 Monoamine oxidase b inhibitors; alzheimer's disease, senile dementia |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004046096A3 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 07/08/2004 | US20040132825 Methods of treating cancer with HDAC inhibitors |
| 07/08/2004 | US20040132121 Method of identifying antibacterial compounds |
| 07/07/2004 | CN1156453C Prepn. of hydroxamic acid |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |